(Bloomberg) Theranos Inc. agreed to settle an early investor’s claims that the embattled blood-testing firm misrepresented its performance and technology in order to raise more than $96 million in funding. Partner Management Fund LP will drop two lawsuits related to the startup’s fumbling of blood tests….
Theranos Settles Suits Accusing Startup of Duping Hedge Fund
This entry was posted in Syndicated. Bookmark the permalink.
